300294.SZ
博雅生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.43
−4.94%Margins
Gross margin
48.1%
EBITDA margin
14.6%
EBIT margin
-0.9%
Net margin
0.2%
FCF margin
-34.0%
0.0%
Return on equity
0.0%
Return on assets
-0.2%
Return on invested capital
0.22x
Asset turnover
-CNY 23.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026